Performance evaluation of the new Sysmex XR9000 hematology system in a clinical setting in comparison with Sysmex XN9100
A new blood count machine performs reliably in clinical settings, though minor refinements are needed for certain measurements at very low concentrations.
The Sysmex XR-9000 hematology analyzer demonstrates robust analytical performance meeting clinical requirements across key CBC parameters, with excellent method agreement against the established XN-9100 system. Minor imprecision above EFLM criteria for red cell indices (MCV, MCH, MCHC) noted at low concentrations but acceptable at clinically relevant levels.
What the study was
- Study design
- Validation study (CLSI H26-A2 and ICSH guidelines)
- Population
- Routine laboratory patients
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Scandinavian Journal of Clinical and Laboratory Investigation
Why it surfaced
Clinical validation of a next-generation hematology analyzer relevant to CBC-based diagnostics pipeline; methodological paper with immediate laboratory implementation implications.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.